Represented a California biotech company in acquiring the stock of a resins manufacturing company with facilities in Linden, New Jersey. Our subsequent representation of this biotech company included the divestiture of the resins manufacturing business to a major chemical company and the handling of ISRA proceedings related to the Linden facilities.